Biography
Amanda received her J.D., magna cum laude, from St John’s University School of Law, where she was Associate Managing Editor for the St. John’s Law Review and was a St. Thomas More Scholar. She received her B.A., summa cum laude, from the University of Albany.
Latest Thinking
Latest Thinking
-
Fifth Circuit Invalidates Board Diversity Rule for Nasdaq-Listed Companies
Blog Post — Weil Governance & Securities Watch
— By
Kaitlin Descovich,
Lyuba Goltser,
Rebecca Grapsas and
Amanda Zoda
— December 21, 2024
The U.S. Court of Appeals for the Fifth Circuit, on December 11, 2024, vacated the prior approval by the Securities and Exchange Commission (SEC) of Nasdaq’s board diversity-related requirements of Nasdaq Listing Rules 5605(f) and 5606. This means that Nasdaq-listed companies are no longer required to have (or explain why they do not have) at […]
The post Fifth Circuit Invalidates Board Diversity Rule for Nasdaq-Listed Companies appeared first on Governance & Securities Watch.
... - Need to Know for 2025: Top 10 Tips for the Form 10-K Alert — By Lyuba Goltser, Howard B. Dicker, Steven Bentsianov, Adé Heyliger, Kaitlin Descovich, Rebecca Grapsas, P.J. Himelfarb and Amanda Zoda — PDF — December 13, 2024
- Looking Ahead to the 2025 Proxy Season: Glass Lewis Annual Policy Survey Results Signal Changes for 2025 Blog Post — Weil Governance & Securities Watch — By Lyuba Goltser, Kaitlin Descovich and Amanda Zoda — November 18, 2024
-
Looking Ahead to the 2025 Proxy Season: ISS Annual Policy Survey Results Focus on Poison Pills, Pay-for-Performance, and Climate and Human Capital Disclosures
Blog Post — Weil Governance & Securities Watch
— By
Lyuba Goltser,
Kaitlin Descovich and
Amanda Zoda
— October 21, 2024
Institutional Shareholder Services (ISS) has released results of its Annual Global Benchmark Policy Survey, which is expected to inform policy changes for the upcoming 2025 proxy season. For U.S. companies, this year’s Global Benchmark Policy Survey, available here, largely focuses on poison pills, executive compensation and environmental and social topics, including greenhouse gas (GHG) emissions and […]
The post Looking Ahead to the 2025 Proxy Season: ISS Annual Policy Survey Results Focus on Poison Pills, Pay-for-Performance, and Climate and Human Capital Disclosures appeared first on Governance & Securities Watch.
... -
Nasdaq Governance Requirements Update: Rule Changes Clarify Phase-In Schedules and Cure Periods for Key Board Requirements
Blog Post — Weil Governance & Securities Watch
— By
Kaitlin Descovich,
Lyuba Goltser,
Adé Heyliger and
Amanda Zoda
— October 09, 2024
The Securities Exchange Commission (the “SEC”) recently issued an order approving Nasdaq’s proposed rule changes amending Rules 5605, 5615 and 5810 to clarify and modify phase-in schedules and cure periods for certain independent director and board committee corporate governance requirements. We have updated our Requirements for Public Company Boards Including IPO Transition Rules guide here […]
The post Nasdaq Governance Requirements Update: Rule Changes Clarify Phase-In Schedules and Cure Periods for Key Board Requirements appeared first on Governance & Securities Watch.
...